Red Rock Resorts' rising ROCE indicates improved business efficiency but may hint at a lack of internal investment opportunities for organic growth. The stock's exceptional performance over the past five years mirrors these trends.
Red Rock Resorts' P/E ratio signifies the risk of enduring negative earnings growth. A drop in P/E could happen if profitability doesn't enhance. A substantial near-term share price surge seems improbable. There exist 4 warning signs for Red Rock Resorts for investors to weigh in on.
Red Rock Resorts' P/E ratio suggests persistent negative earnings growth. A drop in the P/E is likely if profits don't improve, making a robust share price rise improbable soon. Also, there are 4 cautionary signs that investors should heed.
CBRE Equity Research praised the Durango Casino opening by Red Rock, stating they 'nailed it'. Analyst John DeCree predicted that the new casino could surpass forecasted ROI more quickly than expected.
The increasing demand for GLP-1 weight-loss medications indicates that in the next ten years, a significant number of Americans may lose hundreds of millions of pounds collectively. This shift in weight could cause a redistribution of trillions of dollars. Last week,$諾和諾德(NVO.US)$presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
Red Rock Resorts股票討論區
Last week, $諾和諾德(NVO.US)$ presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
folks…..its not a penny stock..easy…relax..been watching this one for a couple years…seems to be grounded. been to one locale..legit
its my first blast reco to some of you that i love….kinda..ish
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US)$+17%, $Workiva(WK.US)$ +15.3%, $Arlo Technologies(ARLO.US)$ +12%, $Array Technologies(ARRY.US)$ +10.3%, $Everbridge(EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals(CPRX.US)$ +9.4%, $奧洛茲美醫療(HALO.US)$ +8.7%, $Velo3D(VLD.US)$ +7.6%, $CyberArk(CYBR.US)$ + 6.2%, $美國血液技術(HAE.US)$ +5.8%, $Jackson Financial(JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise(AXON.US)$ +4.8%,...
• $APi Group(APG.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $23
• $Axos Financial(AX.US)$ : KBW Upgrades to Outperform from Marketperform - PT $56 (from $52)
• $美國銀行(BAC.US)$: Societe Generale Upgrades to Buy from Hold - PT $37.50 (from $40.50)
• $Element Solutions(ESI.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $22 (from $24)
• $Fate Therapeutics(FATE.US)$ : BMO Capital Upgrades...
• $美國雅保(ALB.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $285 (from $215)
• $Alcon(ALC.US)$ : Stephens Upgrades to Overweight from EqualWeight - PT $92 (from $86)
• $Atlantica Sustainable Infrastructure(AY.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $33 (from $38)
• $Coupang(CPNG.US)$ : Citigroup Upgrades to Buy from Neutral - PT $15 (from $29)
• $89bio(ETNB.US)$ : Raymond James Upgrades to Strong Buy from Outp...
$Sorrento Therapeutics Inc(SRNE.US)$ $iBio Inc(IBIO.US)$ $Zosano Pharma Corp(ZSAN.US)$ $Red Rock Resorts(RRR.US)$
**SRNE** entry's below 12 are ideal but an entry between 12-14 is still good as well. SRNE touched 21 last monday and was targeted by hindenburg research for a short seller ra
暫無評論